Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-02 Option Award |
2024-01-04 4:30 pm |
N/A 2033-12-31 |
Werewolf Therapeutics Inc. | HOWL | Seidel-Dugan Cynthia Chief Scientific Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-01-03 Option Award |
2023-01-09 9:36 pm |
N/A 2032-12-31 |
Werewolf Therapeutics Inc. | HOWL | Seidel-Dugan Cynthia Chief Scientific Officer |
115,900 | $0 | 115,900 (Direct) |
View |
| 2022-01-12 Exercise |
2022-01-14 5:58 pm |
N/A N/A |
Werewolf Therapeutics Inc. | HOWL | Seidel-Dugan Cynthia Chief Scientific Officer |
15,532 | $4.77 | 364,972 (Direct) |
View |
| 2022-01-06 Option Award |
2022-01-14 5:58 pm |
N/A 2032-01-05 |
Werewolf Therapeutics Inc. | HOWL | Seidel-Dugan Cynthia Chief Scientific Officer |
79,516 | $0 | 364,972 (Direct) |
View |
| 2022-01-12 Exercise |
2022-01-14 5:58 pm |
N/A N/A |
Werewolf Therapeutics Inc. | HOWL | Seidel-Dugan Cynthia Chief Scientific Officer |
24,199 | $1.56 | 364,972 (Direct) |
View |
| 2022-01-12 Exercise |
2022-01-14 5:58 pm |
N/A 2030-05-19 |
Werewolf Therapeutics Inc. | HOWL | Seidel-Dugan Cynthia Chief Scientific Officer |
39,731 | $0 | 364,972 (Direct) |
View |
| 2020-12-08 Option Award |
2021-05-04 4:31 pm |
N/A 2030-12-07 |
Werewolf Therapeutics Inc. | HOWL | Seidel-Dugan Cynthia Chief Scientific Officer |
157,071 | $0 | 157,071 (Direct) |
View |
Ownership |
2021-04-29 4:57 pm |
N/A N/A |
Werewolf Therapeutics Inc. | HOWL | Seidel-Dugan Cynthia Chief Scientific Officer |
0 | $0 | 285,456 (Direct) |
View |